Silvercrest Asset Management Group LLC Amgen Inc Transaction History

Silvercrest Asset Management Group LLC

$14.1 Billion
Q1 2024

A detailed history of Silvercrest Asset Management Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 231,523 shares of AMGN stock, worth $72.3 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

231,523

Previous 231,204 0.14%

Holding current value

$72.3 Million

Previous $66.6 Million 1.15%

% of portfolio

0.47%

Previous 0.48%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $85,769 - $103,534	319 Added 0.14%	231,523 $65.8 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $2.92 Million - $3.29 Million	-11,414 Reduced 4.7%	231,204 $66.6 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $2.8 Million - $3.47 Million	-12,788 Reduced 5.01%	242,618 $65.2 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $9.19 Million - $10.9 Million	-42,896 Reduced 14.38%	255,406 $56.7 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $1.46 Million - $1.78 Million	-6,477 Reduced 2.13%	298,302 $72.1 Million

Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $477,756 - $607,046	-2,086 Reduced 0.68%	304,779 $80 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $993,011 - $1.12 Million	-4,424 Reduced 1.42%	306,865 $69.2 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $356,446 - $396,663	1,545 Added 0.5%	311,289 $75.7 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $748,149 - $827,648	3,412 Added 1.11%	309,744 $74.9 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $10.8 Million - $12.3 Million	-54,188 Reduced 15.03%	306,332 $68.9 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $838,041 - $981,867	-3,948 Reduced 1.08%	360,520 $76.7 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $828,274 - $918,910	3,546 Added 0.98%	364,468 $88.8 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $12.2 Million - $14.2 Million	54,997 Added 17.98%	360,922 $89.8 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $11.7 Million - $13.9 Million	-54,047 Reduced 15.01%	305,925 $70.3 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $1.06 Million - $1.18 Million	-4,506 Reduced 1.24%	359,972 $91.5 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $249,438 - $306,095	-1,261 Reduced 0.34%	364,478 $86 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $118,820 - $157,588	-652 Reduced 0.18%	365,739 $74.1 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $574,252 - $738,112	3,035 Added 0.84%	366,391 $88.3 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $155,654 - $186,506	894 Added 0.25%	363,356 $70.3 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $7.18 Million - $8.42 Million	43,079 Added 13.49%	362,462 $66.8 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $1.44 Million - $1.63 Million	7,989 Added 2.57%	319,383 $60.7 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $152,175 - $177,637	-853 Reduced 0.27%	311,394 $60.6 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $6.49 Million - $7.32 Million	35,037 Added 12.64%	312,247 $64.7 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $523,721 - $588,252	3,154 Added 1.15%	277,210 $51.2 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $1.52 Million - $1.77 Million	8,959 Added 3.38%	274,056 $46.7 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $3.59 Million - $4.01 Million	21,250 Added 8.71%	265,097 $46.1 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $40.8 Million - $46.6 Million	243,847	243,847 $45.5 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Account

Silvercrest Asset Management Group LLC Amgen Inc Transaction History